- Meitheal Pharmaceuticals - Worldwide Sourcing. Local Connections.
Meitheal, a fully integrated biopharmaceutical company, is unwaveringly committed to supporting access to critical medicines Headquartered in Chicago, Illinois, Meitheal brings to market innovative and impactful biopharmaceutical products with its global strategic partners
- Meitheal Pharmaceuticals, Inc. - LinkedIn
Founded in 2017, Meitheal Pharmaceuticals is a privately owned pharmaceutical company focusing on generic injectable products Headquartered near Chicago, Illinois, Meitheal has an established
- Meitheal Pharmaceuticals Inc. Company Profile | Chicago, IL . . .
Find company research, competitor information, contact details financial data for Meitheal Pharmaceuticals Inc of Chicago, IL Get the latest business insights from Dun Bradstreet
- Meitheal Pharmaceuticals Announces Approval and Launch of . . .
Founded in 2017 and based in Chicago, Meitheal is focused on the development and commercialization of generic injectable medications and, as of 2022, has expanded its focus to include fertility, biologic, and branded products
- Meitheal Pharmaceuticals Announces Launch of Generic . . .
ABOUT MEITHEAL PHARMACEUTICALS, INC Founded in 2017 and based in Chicago, Meitheal is focused on the development and commercialization of generic injectable medications and, as of 2022,
- Meitheal Pharmaceuticals, Inc. - ASHP Midyear 2024
Founded in 2017, Meitheal Pharmaceuticals, Inc is a fully integrated biopharmaceutical company based in Chicago, focused on developing and commercializing generic injectables, fertility, biologic, and branded products
- A Profile of a Lesser-Known Player in the Biosimilar Space . . .
Established in 2017, Meitheal’s majority shareholder is the Chinese active pharmaceutical ingredient manufacturer Nanjing King-Friend (which gained a majority stake in the company in 2019) Meitheal is led by Chief Executive Officer Tom Shea, who has extensive experience in the generic marketplace
|